Recently published scientific papers feature various aspects of pandemic “star” Coronavirus 19. This virus has significantly changed pharma research and production in a variety of unique ways.
This white paper will focus on how research/production efforts might fail under the threats of highly contagious disease viruses, bacteria, and highly active pharmaceutical ingredients. Performing contemporary research safely and producing highly active pharmaceuticals and vaccines will require material isolation and medical product purity. Once identified, contamination paths and bad production procedures will require correction and control.
We will outline possible contamination vulnerabilities in this paper. Flow Sciences and other manufacturers are developing containment options to neutralize such challenges and test methods to certify them. The author will discuss several current enhancements already used and new approaches we are all developing right now!
DOWNLOAD TO LEARN MORE>>>>
DOWNLOAD TO LEARN MORE>>>>